The Minnesota Department of Health (MDH) will offer free mammograms through a televised phone bank on CBS affiliate KEYC-TV and Fox affiliate NEYC-TV in Mankato on Wednesday, April 8. The mammograms are offered through the Sage Screening Program, a state and federally funded program that provides fr

Medidata Solutions, a leading global provider of hosted clinical development solutions, announced that U-Systems, Inc. selected Medidata Rave(R) as its standard for electronic data capture (EDC) to perform the SOMO-INSIGHT clinical study of an automated breast imaging ultrasound system for early det

The Washington Post on Tuesday examined the increasing number of women opting to undergo preventive bilateral mastectomies after being diagnosed with the BRCA1 and BRCA2 genes, which increase the risk of breast cancer. According to a 2007 University of Minnesota study, the percentage of U.S. women w

Scientists at The University of Texas M. D. Anderson Cancer Center have discovered a gene that protects PTEN, a major tumor-suppressor that is reduced but rarely mutated in about half of all breast cancers. The gene Rak helps protect and regulate PTEN, which also is important in several other types

GlaxoSmithKline on Wednesday applied for approval to market its breast cancer drug Tykerb in U.S. and Europe as a first-line treatment for women with advanced, hormone-sensitive breast cancer, the AP/Google.com reports. Tykerb, known as Tyverb in Europe, was approved two years ago in the U.S. as par

Pfizer Inc announced the discontinuation of one of its Phase 3 studies based on statistical assessment for futility: the SUN 1107 Phase 3 study of Sutent® (sunitinib malate) in advanced breast cancer. SUN 1107 evaluated single-agent sunitinib versus single-agent capecitabine for the treatment of a b

A new federally funded University of Pennsylvania School of Medicine study aims to learn whether women at high risk of breast cancer can use exercise to meaningfully reduce their risk of getting the disease. Building on evidence that reducing estrogen in the body reduces cancer risk, and that elite

Brian Rowan, Ph.D., professor of Cancer Research for the Tulane Cancer Center, is studying treatment options for an aggressive type of breast cancer that is prevalent in New Orleans among African-American women triple-negative breast cancer. The term triple-negative refers to the fact that these tum

The answer may surprise you in that studies are finding that late-night exposure to light may diminish levels of a natural cancer-fighting hormone. Dr. David Blask, professor of the practice in the Tulane University School of Medicine Department of Structural and Cellular Biology, is a widely acclai

Women are often told that mammography saves lives. But rarely is the question asked, 'how often?' Researchers writing in the open access journal BMC Medical Informatics and Decision Making, set out to examine how often this life-saving event occurs. Unrealistic expectations may influence a woman's